Event types: Meetings and conferences
24 - 25 May 2018
Gent, BelgiumMedical Biotechnology https://vibconferences.be/event/medical-biotechnology https://tess.elixir-europe.org/events/medical-biotechnology “New research issues in the life sciences require new research tools,” said Nico Callewaert of the VIB-UGent Center for Medical Biotechnology and organizing committee member of this conference. “We are pushing back the limits of bio-analytical and bioengineering tools to arrive at a new technological approach to drug development, diagnostics, vaccines, therapies, etc.” With this conference on Medical Biotechnology VIB will bring together experts in the field to discuss the new developments and future challenges in this field. During four plenary sessions the following topics will be covered: • biopharmaceutical technology; • targeted delivery; • diagnostics & biomarkers; • vaccines. Registration is now open! 2018-05-24 08:45:00 UTC 2018-05-25 18:00:00 UTC VIB Conference Series Universiteit Gent - Aula, 9, Voldersstraat, Gent, Belgium Universiteit Gent - Aula, 9, Voldersstraat Gent Oost-Vlaanderen Belgium 9000  Practical questions: VIB conferences team +32 9 244 66 11 or firstname.lastname@example.org  PhDAcademicsIndustry 250 meetings_and_conferences first_come_first_served medical biomarkers diagnosticsvaccine developmentbiopharmaceutical technologymedical biotechnolgyantiviral immunityviral growth and purificationnext-generation biologicstherapeutic applicationdrug discoverypersonalized medicinebiomoleculartherapeutic antibodiesbiobettersdiagnostic toolsvaccinesdiagnostics & biomarkerstargeted therapeuticstargeted deliveryBiotherapeuticsBiopharmaceuticalsbiopharma
BioData.pt Business Forum: Advanced data management for added value
6 May 2019
Oeiras, PortugalBioData.pt Business Forum: Advanced data management for added value https://www.eventbrite.com/e/forum-biodatapt-empresas-gestao-avancada-de-dados-para-a-criacao-de-valor-tickets-58432946516?aff=eac2 https://tess.elixir-europe.org/events/biodata-pt-business-forum Research and development institutions annually produce zetabytes of biological information, of which only terabytes are used by the bio-industry. There is a large biological information, the big biodata, still to be explored by the bio-industry, which can add value into new products and services. The BioData.pt Business Forum: advanced data management for added value, organized by BioData.pt and PBio, will bring together four national companies related to the health sector, the sea, agriculture and bioindustry, and tell their stories to inspire new ideas and new businesses. There will also be an opportunity to discuss best practices in curation, management and use of biodata, as well as the use of bioinformatics tools essential to its success. 2019-05-06 14:30:00 UTC 2019-05-06 18:00:00 UTC Biodata.pt Instituto Gulbenkian de Ciência (IGC), 6, Rua Quinta Grande, Oeiras, Portugal Instituto Gulbenkian de Ciência (IGC), 6, Rua Quinta Grande Oeiras Portugal 2780-156 Instituto Gulbenkian de CiênciaBiodata.pt - Elixir's portuguese node of the european projec email@example.com  Clinical ScientistsbioinformaticiansBiologists, Genomicists, Computer Scientistssoftware developers, bioinformaticiansbiology and bioinformatics sophomore undergraduatesbiocurators Institutions and other external Institutions or individualsIndustry health professionalsplant researchersBiomedical researchers studies human diseases or developmental biology 120 meetings_and_conferences  Biodata, Bioinformatics, Biodata
8 - 9 December 2020
Gent, BelgiumTranslational Immunology https://www.vibconferences.be/events/translational-immunology?utm_source=Event%20website&utm_medium=Event%20post&utm_campaign=TransImmu20&utm_term=Immunology&utm_content=Elixir%20Tess https://tess.elixir-europe.org/events/translational-immunology-fe17b83a-fab1-413f-94c3-9c6a1ecac893 Translational Immunology 8-9 DECEMBER 2020, GHENT, BELGIUM Due to the Coronavirus, Translational Immunology and the satellite BIS meeting were postponed from 26-27 March 2020 to the end of the year. We are happy to confirm the new date: 8-9 December 2020. The aim of this conference is to bridge the translational gap in immunopathology, bringing together clinicians, research scientists and industry partners to discuss prominent advances from the bench to the clinic. The different sessions will have a particular focus on precision medicine in general, starting from disease-oriented cases and lessons learned. Innovative and alternative therapeutic strategies in immune-mediated disorders will be presented, besides the regulatory challenges that companies and researchers are dealing with. Deadlines: - Abstract submission: 5 October 2020 - Early Bird deadline: 27 October 2020 - Late Registration deadline: 24 November 2020 Speakers: Rosa Bacchetta Stanford Medicine, US Dirk Elewaut VIB-UGent Center for Inflammation Research, BE Alain Fischer Assistance publique – Hôpitaux de Paris, FR Martin Guilliams VIB-UGent Center for Inflammation Research, BE Pleun Hombrink Sanquin, NL Bengt Hoepken Clinical Program Director, UCB Pharma, DE Isabelle Huys KU Leuven, BE Christophe Lahorte National Innovation Office & Scientific-Technical Advice Unit - (Famhp), BE Bart Lambrecht VIB-UGent Center for Inflammation Research, BE Antonio Lanzavecchia Institute for Research in Biomedicine, CH Sophie Lucas de Duve Institute, UCLouvain, BE Bénédicte Machiels FARAH Center, ULiège, BE Melanie Matheu CEO, Founder at Prellis Biologics, Inc., US Massimiliano Mazzone VIB-KU Leuven Center for Cancer Biology, BE Kathy McCoy University of Calgary, CA Eoin McKinney University of Cambridge, UK Fiona Powrie Kennedy Institute of Rheumatology, University of Oxford, UK Federica Sallusto Institute for Research in Biomedicine, CH Georg Schett Friedrich-Alexander University Erlangen-Nürnberg, DE Marvin van Luijn Erasmus MC, University Medical Center Rotterdam MS Center ErasMS, NL Location: De Bijloke, Jozef Kluyskensstraat 2, 9000 Gent Hashtag: #TransImmu20 2020-12-08 09:00:00 UTC 2020-12-09 17:00:00 UTC VIB Conferences Music Center De Bijloke, 2, Jozef Kluyskensstraat, Gent, Belgium Music Center De Bijloke, 2, Jozef Kluyskensstraat Gent Oost-Vlaanderen Belgium 9000 Immunoprecipitation experiment Immunology Immunoproteins and antigens   PhDPhD studentsAcademicsindustry 600 meetings_and_conferences  ImmunologyImmunogenicityImmunogenomicsMetabolism of Immune Cellsantibodiestherapeutic antibodies
Genome Engineering and Synthetic Biology (4th edition)
23 - 24 September 2021
Gent, BelgiumGenome Engineering and Synthetic Biology (4th edition) https://www.vibconferences.be/events/genome-engineering-and-synthetic-biology-4th-edition https://tess.elixir-europe.org/events/genome-engineering-and-synthetic-biology-4th-edition Genome Engineering and Synthetic Biology are revolutionizing Life Sciences. Driven by advances in the CRISPR-toolbox for rapid, cheap, multiplex modification of genomes and breakthroughs in DNA synthesis technologies, the pace of progress enabled by these tools in the last years has been breathtaking. The first three editions (September 2013, January 2016, January 2018) were a roaring success and we are pleased to announce the 4th edition of GESB in beautiful Ghent in September, 2020. Travel Grants We offer 5 travel grants to international attendees, which will reimburse travel costs up to 400 Euros. Are you interested in attending GESB20 and want to have a chance on a travel grant? Submit your motivation below by clicking on the 'Apply for a grant' button before 24 June 2021. The organizing committee will notify you of your travel grant acceptance by the end of June. No registration is needed before submitting a travel grant proposal. When you’re awarded with a travel grant you will receive a practical email containing the next steps. Note that being awarded a travel grant does not mean being registered for the conference. Poster information: Format: A0 (841 x 1189 mm / 33.1 x 46.8 in), portrait orientation Deadlines: • Early Bird: 30 July 2020 • Late Registration: 26 August 2020 • Abstract deadline: 2 July 2020 Speakers: • Edward Lemke - Institute of Molecular Biology (IMB), DE, Johannes Gutenberg University (JGU), DE & EMBL, DE • Sarah Christine Heilshorn - Stanford University, US • Jane Langdale - University of Oxford, UK • George Guo-Qiang Chen - Tsinghua University, CN • Jason Gammack - Inscripta, US • Janice Chen - Mammoth Biosciences, US • Dan Voytas - University of Minnesota, US & Co-Founder & CSO, Calyxt, US • Alexis Komor - University of California, US • Fred Van Ex - Inari Agriculture, BE • Ross Sozzani - NC State Univeristy, US • Bruno Correia - EPFL, CH • Patrick Yizhi Cai - Manchester Institute of Biotechnology, University of Manchester, UK • Tilmann Buerckstuemmer - Aelian Biotechnology, AT • Peter Smibert - New York Genome Center, Techn Innovation lab, US • Tara Deans - University of Utah, US • Jonathan Gootenberg - McGovern Institute, MIT, US • Steve Harvey - CEO Camena Biosciences, UK • Rob Marchmont - VP Sphere Fluidics, UK • Charlie Silver - CEO Mission Bio, US • Bryan Dickinson - The University of Chicago, US • Holger Puchta - Botanical Institute, Karlsruhe Institute of Technology (KIT), DE • Ping-Wei Ho - VIB-KU Leuven Center for Microbiology, BE • And more to come! 2021-09-23 08:00:00 UTC 2021-09-24 18:00:00 UTC VIB De Bijloke, Bijlokekaai 7, 7, Bijlokekaai, Gent, Belgium De Bijloke, Bijlokekaai 7, 7, Bijlokekaai Gent Oost-Vlaanderen Belgium 9000  VIB Conferences team - +32(0)92446611 - firstname.lastname@example.org TakaraTwist Bioscience IndustryPhD studentsAcademics 400 meetings_and_conferences  genome engineeringSynthetic biologycrisprdna synthetistechnologies
Note, this map only displays events that have geolocation information in TeSS.
For the complete list of events in TeSS, click the grid tab.